Home
Scholarly Works
Outcomes of frailty subgroups of older adults (age...
Journal article

Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis

Authors

Mian H; Martin TG; Pond GR; Asoori S; Popat R; Kastritis E; Martinez-Lopez J; Abdallah N; Chhabra S; Parrondo R

Journal

Leukemia, Vol. 39, No. 5, pp. 1252–1255

Publisher

Springer Nature

Publication Date

May 1, 2025

DOI

10.1038/s41375-025-02552-3

ISSN

0887-6924

Contact the Experts team